Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C
Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C
复制标题
DOI：
10.1136/bjo.86.2.244
复制
发表时间：
2002-02
影响因子：
4.1
通讯作者：
C. L. Shields;Hakan Demirci;J. A. Shields;Christopher Spanich
中科院分区：
文献类型：
--
作者：
C. L. Shields;Hakan Demirci;J. A. Shields;Christopher Spanich
Conjunctival primary acquired melanosis is the most important precursor of conjunctival malignant melanoma.1,2 Primary acquired melanosis appears as flat, patchy, non-cystic pigmentation in the conjunctival epithelium and can remain dormant for years or show slow progression.2 Studies have shown that it leads to conjunctival melanoma in approximately 1% to 30% patients.3,4 Treatment of primary acquired melanosis includes observation, excisional biopsy, alcohol epitheliectomy, cryotherapy, and topical chemotherapy.1,2,5,6 We illustrate a dramatic case where topical chemotherapy provided complete regression of advanced, aggressive primary acquired melanosis. A 73 year old white man had noted slowly progressive pigmentation on the surface of his right eye for 5 years. A biopsy revealed intraepithelial conjunctival melanosis with atypia. The patient was referred to the Oncology Service at Wills Eye Hospital for evaluation and management. On examination, his visual acuity was 20/20 right …
